Nitroimidazo-oxazole compound DNDI-VL-2098: an orally effective preclinical drug candidate for the treatment of visceral leishmaniasis.

Gupta, S; Yardley, V; Vishwakarma, P; Shivahare, R; Sharma, B; Launay, D; Martin, D; Puri, SK; (2014) Nitroimidazo-oxazole compound DNDI-VL-2098: an orally effective preclinical drug candidate for the treatment of visceral leishmaniasis. The Journal of antimicrobial chemotherapy. ISSN 0305-7453 DOI: https://doi.org/10.1093/jac/dku422

Permanent Identifier

Use this Digital Object Identifier when citing or linking to this resource.

https://doi.org/10.1093/jac/dku422

Abstract

Share

Download

Full text not available from this repository.

Downloads

View details

Metrics & Citations


Google Scholar